National Institutes of Health ,

The authors thank Y. Oono and M. Balsera for invaluable contributions to the joint development of SMD and J. Gullingsrud for many suggestions in the preparation of the manuscript. Images of molecular systems were produced with the program VMD (Humphrey et al., 1996). This work was supported by grants from the National Institute of Health (PHS 5 P41 RR05969-04), the National Science Foundation (BIR-9318159, BIR 94-23827 (EQ)), and the Roy J. Carver Charitable Trust. 

This work has been supported by the U.S. National Science Foundation (grant MCB-9314854) and the U.S. National Institutes of Health s National Center for Research Resources (grant RR08102 to the UNC/Duke Computational Structural Biology Resource). 

This research was supported by grants from the Israel Science Foundation, Israel Science Ministry and the National Institutes of Health to RE. 

The primary developers of NAMD 1 were M. Nelson, W. Humphrey, A. Gursoy, A. Dalke and R. Brunner. The primary developers of NAMD 2 were J. Phillips, A. Shinozaki, R. Brunner, N. Krawetz, M. Bhandarkar and A. Gursoy. NAMD development was performed at the National Institutes of Health Resource for Concurrent Biological Computing under the supervision of principal investigators L.V. Kale, R. Skeel, and K. Schulten. This work was... 

In 1964 Douglas Cart Engelbart (Stanford Research Institute in California) developed the mouse as an input device and Bill Enghsh built its prototype from a carved block of wood with a single red button. Shortly thereafter, the mouse was used at the Lister Hill Center of the National Institutes of Health for the input of chemical structures. 

The International Human Genome Sequencing Consor tium was headed by Francis S Collins of the U S National Institutes of Health J Craig Venter led the Celera effort... 

The National Institutes of Health-EPA mass spectral library is used to identify analyzed components of a sample by comparing their mass spectra with those of authentic specimens held in the library. 

GenBank National Institute of Health STN bio-sequences, DNA/RNA sequences... 

Sodium Silicate-Oil and Hac rdous Materials—Technical Assistance Data System, National Institute of Health, Washington, D.C. (an on-line database). 

Research on an hCG vaccine has been conducted over the past 15 years. WHO has conducted a phase I clinical study in AustraUa, using a vaccine based on a synthetic C-terminal peptide (109—141) of P-hCG conjugated to Diptheria Toxoid (CTP-DT), that showed potentially effective contraceptive levels of antibodies were produced in vaccinated women without any adverse side effects. Phase II clinical studies are under consideration to determine if the immune response, raised to its prototype anti-hCG vaccine, is capable of preventing pregnancy in fertile women volunteers (115). While research on the C-terminal peptide from the P-subunit of hCG has been carried out under the auspices of WHO, research supported by the Population Council and the National Institutes of Health has involved two alternative vaccine candidates (109,116,118). 

En2ymes Therapeutic" in ECT 3rd ed., Vol. 9, pp. 225—240, by D. A. Cooney, G. Stergis, and H. N. Jayaram, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health. 

National Toxicology Program Technical Report, National Institutes of Health pubheation number 88-2582, U.S. Department of Health and Human Services, PubHc Health Service, National Institutes of Health, Washiagton, D.C., 1987. 

Department of Chemistry, State University of New York, Stony Brook, NY 11794. Partial support was provided by the National Institutes of Health (Grant No. CA22741). 

National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina... 

D. Computational Biophysics Related at the National Institutes of Health (NIH)... 

Department of Chemistry, Vanderbilt University, XashvUle, Tenn. 37235. This work was supported b - grants from the National Science Foundation and the National Institute of Health. 

Present address National Drug Company, Research Laboratories, Philadelphia 44, Pennsylvania. Work done in the Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Ofg. Syntheses, 81, 56 (1951). 

The research leading to the syntheses which are outlined in Part Two was generously supported over the years by the National Institutes of Health, the National Science Foundation and Pfizer, Inc. 

A document from the U.S. Centers for Disease Control and Prevention and National Institutes of Health" describes, in detail, the different BSC designs and operating parameters. This document is easily available on the Internet and only a short summary will be provided here. For more detail regarding operation, design, use, testing, protection, etc. the reader is referred to the latest edition of the CDC-NIH document. 

---